VDP-34: Autophagy Activators

Crowd Funded Cures' mission is to implement pay-for-success smart contracts (an on-chain version of Social Impact Bonds or SIBs) to incentivise repurposing of generic drugs. The SIB mechanism incentivises impact investors (such as VitaDAO token holders) to fund IPNFTs holding encrypted Phase II/III randomised controlled trial (RCT) data to sell to payers in exchange for outcome payments or a subsidized price for the newly labelled generic from a generic drug repurposing fund if the RCT is successful and/or the repurposed generic obtains regulatory approval. The fund can also be crowdfunded from the public using disease-specific NFTs or backed by payers such as governments, health insurers, or large philanthropy. We propose VitaDAO provide $40,000 of funding to Crowd Funded Cures to commission a feasibility study from Guidehouse or another leading consulting firm on this new model of research funding ("generic drug and nutraceutical repurposing pay-for-success contracts") to kickstart potential future mechanisms that VitaDAO could support in the future.